Nasal route favors the induction of CD4 + T cell responses in the liver of HBV-carrier mice immunized with a recombinant hepatitis B surface- and core-based therapeutic vaccine
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 153, 23-32
Abstract
No abstract availableKeywords
Funding Information
- Cuba-France cooperation
This publication has 40 references indexed in Scilit:
- Mobilizing monocytes to cross-present circulating viral antigen in chronic infectionJournal of Clinical Investigation, 2013
- CD40 Activation Rescues Antiviral CD8+ T Cells from PD-1-Mediated ExhaustionPLOS Pathogens, 2013
- Adeno-Associated Virus-Mediated Gene Transfer Leads to Persistent Hepatitis B Virus Replication in Mice Expressing HLA-A2 and HLA-DR1 MoleculesJournal of Virology, 2013
- Hepatitis B infection: current concepts and future challengesQJM: An International Journal of Medicine, 2012
- Liver antigen-presenting cellsJournal of Hepatology, 2011
- Chronic Infections with Hepatotropic Viruses: Mechanisms of Impairment of Cellular Immune ResponsesSeminars in Liver Disease, 2007
- A long-term follow-up study on hepatitis B surface antigen–positive patients undergoing allogeneic hematopoietic stem cell transplantationBlood, 2005
- Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variantsEuropean Journal of Immunology, 2003
- Escaping High Viral Load ExhaustionJournal of Experimental Medicine, 2002
- Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.Journal of Experimental Medicine, 1991